ScreenerHero
ALINTIntegraGen SA
EPA · FR · Healthcare · Biotechnology · integragen.com
0.1785EUR+1.71%Mkt Cap: 1.28M $P/E: —

IntegraGen SA provides researchers with sequencing solutions, data management tools, and biostatistical, and bioinformatics support services in France. The company's genomic pharma services DNA sequencing for oncology an…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
argenx SE
$61.34BUSDP/E 39.8
UCB
UCB SA
$45.95BUSDP/E 19.6
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.26BUSDP/E 26.6
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap1.28M $
Enterprise Value376.91K $
Revenue (TTM)5.46M $
Gross Profit5.45M $
Net Income (TTM)-186.30K $
Revenue/Share0.8272 USD
Last Price0.1785 EUR
Fiscal Year EndDec 2025
MR QuarterDec 2025
Employees37
CountryFR
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-0.13
EV/Revenue0.07
P/S0.23
P/B-1.27
EPS (TTM)-0.04
EPS (Forward)—
52W Range
0.115026% of range0.3610
52W High0.3610 EUR
52W Low0.1150 EUR
Profitability
Gross Margin40.03%
Oper. Margin-56.57%
EBITDA Margin-53.92%
Profit Margin-1.37%
ROE-8.52%
ROA-2.14%
Growth
Revenue Growth-44.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-1.71M $
CapEx (TTM)—
FCF Margin-3.31%
FCF Yield-14.05%
Net Debt-881.09K $
Net Debt/EBITDA0.30
Balance Sheet
Debt/Equity0.56
Current Ratio0.95
Quick Ratio0.85
Book Value/Sh-0.1380 EUR
Cash/Share0.1690 EUR
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 EUR
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.6.61M
Float—
Insiders65.90%
Institutions0.00%
Technical
SMA 500.1748 (+2.1%)
SMA 2000.1708 (+4.5%)
Beta0.34
S&P 52W Chg18.16%
Avg Vol (30d)31.30K
Avg Vol (10d)28.39K
Technical Indicators
RSI (14)50.3
MACD0.0020
MACD Signal0.0016
MACD Hist.+0.0004
BB Upper0.2196 EUR
BB Middle0.1745 EUR
BB Lower0.1294 EUR
BB Width51.74%
ATR (14)0.0144 EUR
Vol Ratio (20d)0.02x